Atlas Trials

Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's Disease

Clinical trial NCT04566003 · COMPLETED

Trial details

NCT number
NCT04566003
Sponsor
Genentech, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease (AD)
Start date
2020-10-26
Primary completion
2023-06-27
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.